Outset Medical (OM) EBIT Growth (1y) (2020 - 2026)
Outset Medical (OM) EBIT Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 74.18% |
| 10 | Outset Medical | 77,625.92 | -286.57 Mn | 12.10 Mn | -3.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.17% |
| Dec 31, 2025 | 19.35% |
| Sep 30, 2025 | 33.67% |
| Jun 30, 2025 | 45.18% |
| Mar 31, 2025 | 55.57% |
| Dec 31, 2024 | 41.48% |
| Sep 30, 2024 | 47.55% |
| Jun 30, 2024 | 29.24% |
| Mar 31, 2024 | 15.12% |
| Dec 31, 2023 | 6.20% |
| Sep 30, 2023 | -10.87% |
| Jun 30, 2023 | 0.56% |
| Mar 31, 2023 | -19.22% |
| Dec 31, 2022 | 2.39% |
| Sep 30, 2022 | -36.04% |
| Jun 30, 2022 | -46.19% |
| Mar 31, 2022 | -22.91% |
| Dec 31, 2021 | -29.05% |
| Sep 30, 2021 | 26.01% |
| Jun 30, 2021 | -20.06% |